Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 5, 2020Tadalafil 26 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1438-2020Class IITerminatedAug 5, 2020Tadalafil 18 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1437-2020Class IITerminatedAug 5, 2020Tadalafil 12 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1436-2020Class IITerminatedAug 5, 2020Sildenafil 50 mg TrocheLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1435-2020Class IITerminatedAug 5, 2020Progesterone Modified Release 200 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1434-2020Class IITerminatedAug 5, 2020Progesterone Modified Release 100 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1433-2020Class IITerminatedAug 5, 2020Progesterone 50 mg Modified Release CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1432-2020Class IITerminatedAug 5, 2020Progesterone 200 mg TrocheLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1431-2020Class IITerminatedAug 5, 2020ProgesteroneLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1430-2020Class IITerminatedAug 5, 2020Progesterone 300 mg TrocheLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1429-2020Class IITerminatedAug 5, 2020Progesterone 150 mg TrocheLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1428-2020Class IITerminatedAug 5, 2020ProgesteroneLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1427-2020Class IITerminatedAug 5, 2020Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsulesLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1426-2020Class IITerminatedAug 5, 2020Minoxidil/Biotin 1.25mg/5mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1425-2020Class IITerminatedAug 5, 2020Formula 82MLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1424-2020Class IITerminatedAug 5, 2020Formula 82FLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1423-2020Class IITerminatedAug 5, 2020Finasteride Plus 1.25mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1422-2020Class IITerminatedAug 5, 2020Estriol 8 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1421-2020Class IITerminatedAug 5, 2020Estriol 6 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1420-2020Class IITerminatedAug 5, 2020D-Biotin 300 mg CapsuleLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1419-2020Class IITerminatedAug 5, 2020Calcium citrate tetrahydrate USP powderLack of Processing Controls (lack of assurance of conformity to specifications).MasterPharm LLC · D-1418-2020Class IITerminatedAug 5, 2020Lisinopril Tablets USPPresence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mgLupin Pharmaceuticals Inc. · D-1413-2020Class IITerminatedAug 5, 2020Saniderm ADVANCED HAND SANITIZERCGMP Deviations: Product was found to be below the label claim for ethanol content and the presence of undeclared methanol.Polarized LLC · D-1412-2020Class IITerminatedAug 5, 2020Handese Advanced Instant Hand SanitizerSubpotent Drug: Product was found to be subpotent. Product also has high pH levelsWorld Event Promotions, LLC · D-1411-2020Class IIITerminatedAug 5, 2020Skin Medica Acne SystemSUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.Allergan PLC · D-1410-2020Class IIITerminatedAug 5, 2020Skin Medica Acne Treatment LotionSUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.Allergan PLC · D-1409-2020Class ITerminatedAug 5, 2020Saniderm ADVANCED HAND SANITIZERChemical Contamination: Product contains undeclared methanol.Uvt Inc · D-1407-2020Class IITerminatedJul 29, 2020Walker Hand SanitizerIncorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.Walker Emulsions Inc · D-1417-2020Class IITerminatedJul 29, 2020Walker Emulsions Hand SanitizerIncorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.Walker Emulsions Inc · D-1416-2020Class ITerminatedJul 29, 2020Mystic Shield PROTECTIONChemical Contamination: Presence of Undeclared MethanolTransliquid Technologies, LLC · D-1408-2020Class IITerminatedJul 29, 2020Cefdinir for Oral Suspension USPSuperpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.Lupin Pharmaceuticals Inc. · D-1406-2020Class IIITerminatedJul 29, 2020Famotidine InjectionTEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.HF Acquisition Co. LLC · D-1392-2020Class IIITerminatedJul 22, 2020Fosaprepitant for InjectionLabeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg /...Fresenius Kabi USA, LLC · D-1391-2020Class IITerminatedJul 22, 2020Lidothol PatchCGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.Preferred Pharmaceuticals, Inc. · D-1390-2020Class IITerminatedJul 22, 2020AuryxiacGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia.Keryx Biopharmaceuticals, Inc. · D-1389-2020Class IIITerminatedJul 22, 2020Proparacaine Hydrochloride Ophthalmic SolutionChemical contamination; out of specification results obtained for equipment cleaning residue rinse sampleAkorn, Inc. · D-1388-2020Class IITerminatedJul 22, 2020Carbamazepine 200 mg TabletsFAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.RemedyRepack Inc. · D-1387-2020Class IIOngoingJul 22, 2020Metformin Hydrochloride Extended-Release Tablets USPCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelGranules Pharmaceuticals Inc · D-1386-2020Class IITerminatedJul 22, 2020Metformin Hydrochloride Extended-Release Tablets USP 1000 mgCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelLupin Pharmaceuticals Inc. · D-1385-2020Class IITerminatedJul 22, 2020Metformin Hydrochloride Extended-Release Tablets USP 500 mgCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelLupin Pharmaceuticals Inc. · D-1384-2020